gumi Inc. (TYO:3903)
616.00
-14.00 (-2.22%)
Aug 1, 2025, 3:30 PM JST
Regulus Therapeutics Revenue
In the fiscal year ending April 30, 2025, gumi Inc. had annual revenue of 8.94B JPY, down -25.89%. gumi Inc. had revenue of 1.54B in the quarter ending April 30, 2025, a decrease of -54.78%.
Revenue
8.94B
Revenue Growth
-25.89%
P/S Ratio
3.41
Revenue / Employee
23.66M
Employees
689
Market Cap
30.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 8.94B | -3.12B | -25.89% |
Apr 30, 2024 | 12.07B | -3.94B | -24.63% |
Apr 30, 2023 | 16.01B | -2.93B | -15.48% |
Apr 30, 2022 | 18.94B | 314.00M | 1.69% |
Apr 30, 2021 | 18.63B | -1.20B | -6.05% |
Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sony Group | 12.96T |
Nintendo | 1,164.92B |
Keyence | 1,073.00B |
Tokyo Electron | 2,431.57B |
Advantest | 904.76B |
Fujitsu | 3,540.69B |
NEC Corporation | 3,448.79B |
NTT DATA Group | 4,638.72B |